Cigna Investments’s Nutrien NTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $553K | Buy |
8,772
+295
| +3% | +$20.6K | 0.07% | 242 |
|
|
2026
Q1 | $638K | Sell |
8,477
-408
| -5% | -$29.1K | 0.1% | 194 |
|
|
2025
Q4 | $549K | Hold |
8,885
| – | – | 0.08% | 215 |
|
|
2025
Q3 | $522K | Hold |
8,885
| – | – | 0.07% | 231 |
|
|
2025
Q2 | $517K | Sell |
8,885
-302
| -3% | -$17.1K | 0.09% | 218 |
|
|
2025
Q1 | $456K | Hold |
9,187
| – | – | 0.08% | 234 |
|
|
2024
Q4 | $411K | Hold |
9,187
| – | – | 0.07% | 262 |
|
|
2024
Q3 | $442K | Sell |
9,187
-135
| -1% | -$6.51K | 0.08% | 246 |
|
|
2024
Q2 | $475K | Hold |
9,322
| – | – | 0.09% | 217 |
|
|
2024
Q1 | $507K | Hold |
9,322
| – | – | 0.1% | 210 |
|
|
2023
Q4 | $528K | Hold |
9,322
| – | – | 0.11% | 187 |
|
|
2023
Q3 | $578K | Sell |
9,322
-95
| -1% | -$6.01K | 0.13% | 156 |
|
|
2023
Q2 | $557K | Sell |
9,417
-283
| -3% | -$18K | 0.1% | 191 |
|
|
2023
Q1 | $716K | Sell |
9,700
-603
| -6% | -$46.5K | 0.14% | 145 |
|
|
2022
Q4 | $752K | Sell |
10,303
-113
| -1% | -$8.93K | 0.16% | 140 |
|
|
2022
Q3 | $873K | Buy |
10,416
+1
| +0% | +$86 | 0.19% | 111 |
|
|
2022
Q2 | $827K | Sell |
10,415
-66
| -0.6% | -$6.41K | 0.16% | 131 |
|
|
2022
Q1 | $1.08M | Buy |
10,481
+1,927
| +23% | +$160K | 0.13% | 148 |
|
|
2021
Q4 | $643K | Sell |
8,554
-95
| -1% | -$6.65K | 0.05% | 310 |
|
|
2021
Q3 | $561K | Hold |
8,649
| – | – | 0.04% | 396 |
|
|
2021
Q2 | $524K | Buy |
8,649
+13
| +0.2% | +$769 | 0.04% | 425 |
|
|
2021
Q1 | $465K | Buy |
8,636
+57
| +0.7% | +$3.1K | 0.03% | 464 |
|
|
2020
Q4 | $413K | Buy |
8,579
+380
| +5% | +$16.8K | 0.03% | 458 |
|
|
2020
Q3 | $321K | Sell |
8,199
-162
| -2% | -$5.9K | 0.03% | 468 |
|
|
2020
Q2 | $267K | Sell |
8,361
-185
| -2% | -$6.44K | 0.03% | 584 |
|
|
2020
Q1 | $290K | Hold |
8,546
| – | – | 0.04% | 464 |
|
|
2019
Q4 | $365K | Buy |
8,546
+43
| +0.5% | +$2.08K | 0.04% | 460 |
|
|
2019
Q3 | $407K | Sell |
8,503
-268
| -3% | -$13.7K | 0.04% | 447 |
|
|
2019
Q2 | $482K | Sell |
8,771
-115
| -1% | -$6K | 0.05% | 399 |
|
|
2019
Q1 | $466K | Hold |
8,886
| – | – | 0.05% | 403 |
|
|
2018
Q4 | $418K | Buy |
8,886
+588
| +7% | +$30.7K | 0.04% | 390 |
|
|
2018
Q3 | $441K | Sell |
8,298
-290
| -3% | -$16.1K | 0.04% | 411 |
|
|
2018
Q2 | $464K | Buy |
+8,588
| New | +$426K | 0.03% | 442 |
|
Other funds holding NTR
Cigna Investments's NTR Position: Q2 2026 in Review
Cigna Investments increased its Nutrien (NTR) stake by 3.5% in Q2 2026, buying an estimated $20.6K and bringing the position to 8,772 shares worth $553K. The position accounts for 0.07% of the portfolio, ranked #242.
Cigna Investments first reported a position in NTR in Q2 2018 and has held it in 33 quarters since. The position peaked at $1.08M in Q1 2022. 734 funds tracked by Wall St. Rank hold NTR as of Q2 2026.
- Cigna Investments held 8,772 shares of Nutrien worth $553K as of Q2 2026.
- Cigna Investments bought 295 Nutrien shares in Q2 2026, an estimated $20.6K.
- Nutrien made up 0.07% of Cigna Investments's portfolio in Q2 2026, its #242 holding.
- Cigna Investments first reported a position in Nutrien in Q2 2018 and has held it in 33 quarters since.
- Cigna Investments's Nutrien position peaked at $1.08M in Q1 2022.
- 734 funds tracked by Wall St. Rank held Nutrien as of Q2 2026.
Based on Cigna Investments's 13F filing for Q2 2026, filed 21 Jul 2026.